← Open Payments lookup

SIDNEY BERRYMAN: Open Payments

NPI 1730892530 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,473 in 95 payments from 19 companies in 2025. Trend: 2023 $1,083 · 2024 $1,721 · 2025 $1,473

Food & beverage: $1,473
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP17$325
ABBVIE INC.29$222
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$163
Phathom Pharmaceuticals, Inc.2$142
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$141
Axsome Therapeutics, Inc.6$108
PFIZER INC.4$62
Takeda Pharmaceuticals U.S.A., Inc.3$46
Novo Nordisk Inc3$44
Lilly USA, LLC2$39

Products named: VOQUEZNA, BREZTRI, CAPLYTA, AIRSUPRA, RELISTOR, QULIPTA, UBRELVY, Auvelity.

Industry payments across AL — which companies pay providers there.